Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Psychoactive Substance Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Stimulants
1.2.3 Cannabinoids
1.2.4 Hallucinogens
1.2.5 Depressants
1.3 Market by Application
1.3.1 Global New Psychoactive Substance Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Neuropathic Disorders
1.3.4 Spasticity
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Psychoactive Substance Market Perspective (2018-2033)
2.2 New Psychoactive Substance Growth Trends by Region
2.2.1 Global New Psychoactive Substance Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 New Psychoactive Substance Historic Market Size by Region (2018-2023)
2.2.3 New Psychoactive Substance Forecasted Market Size by Region (2024-2033)
2.3 New Psychoactive Substance Market Dynamics
2.3.1 New Psychoactive Substance Industry Trends
2.3.2 New Psychoactive Substance Market Drivers
2.3.3 New Psychoactive Substance Market Challenges
2.3.4 New Psychoactive Substance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Psychoactive Substance Players by Revenue
3.1.1 Global Top New Psychoactive Substance Players by Revenue (2018-2023)
3.1.2 Global New Psychoactive Substance Revenue Market Share by Players (2018-2023)
3.2 Global New Psychoactive Substance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by New Psychoactive Substance Revenue
3.4 Global New Psychoactive Substance Market Concentration Ratio
3.4.1 Global New Psychoactive Substance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Psychoactive Substance Revenue in 2022
3.5 New Psychoactive Substance Key Players Head office and Area Served
3.6 Key Players New Psychoactive Substance Product Solution and Service
3.7 Date of Enter into New Psychoactive Substance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 New Psychoactive Substance Breakdown Data by Type
4.1 Global New Psychoactive Substance Historic Market Size by Type (2018-2023)
4.2 Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033)
5 New Psychoactive Substance Breakdown Data by Application
5.1 Global New Psychoactive Substance Historic Market Size by Application (2018-2023)
5.2 Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America New Psychoactive Substance Market Size (2018-2033)
6.2 North America New Psychoactive Substance Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America New Psychoactive Substance Market Size by Country (2018-2023)
6.4 North America New Psychoactive Substance Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Psychoactive Substance Market Size (2018-2033)
7.2 Europe New Psychoactive Substance Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe New Psychoactive Substance Market Size by Country (2018-2023)
7.4 Europe New Psychoactive Substance Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Psychoactive Substance Market Size (2018-2033)
8.2 Asia-Pacific New Psychoactive Substance Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific New Psychoactive Substance Market Size by Region (2018-2023)
8.4 Asia-Pacific New Psychoactive Substance Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Psychoactive Substance Market Size (2018-2033)
9.2 Latin America New Psychoactive Substance Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America New Psychoactive Substance Market Size by Country (2018-2023)
9.4 Latin America New Psychoactive Substance Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Psychoactive Substance Market Size (2018-2033)
10.2 Middle East & Africa New Psychoactive Substance Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa New Psychoactive Substance Market Size by Country (2018-2023)
10.4 Middle East & Africa New Psychoactive Substance Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Detail
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals New Psychoactive Substance Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 GW Pharmaceuticals
11.2.1 GW Pharmaceuticals Company Detail
11.2.2 GW Pharmaceuticals Business Overview
11.2.3 GW Pharmaceuticals New Psychoactive Substance Introduction
11.2.4 GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.2.5 GW Pharmaceuticals Recent Development
11.3 Teewinot Life Sciences
11.3.1 Teewinot Life Sciences Company Detail
11.3.2 Teewinot Life Sciences Business Overview
11.3.3 Teewinot Life Sciences New Psychoactive Substance Introduction
11.3.4 Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2018-2023)
11.3.5 Teewinot Life Sciences Recent Development
11.4 AusCann
11.4.1 AusCann Company Detail
11.4.2 AusCann Business Overview
11.4.3 AusCann New Psychoactive Substance Introduction
11.4.4 AusCann Revenue in New Psychoactive Substance Business (2018-2023)
11.4.5 AusCann Recent Development
11.5 Cannabics Pharmaceuticals
11.5.1 Cannabics Pharmaceuticals Company Detail
11.5.2 Cannabics Pharmaceuticals Business Overview
11.5.3 Cannabics Pharmaceuticals New Psychoactive Substance Introduction
11.5.4 Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.5.5 Cannabics Pharmaceuticals Recent Development
11.6 Tilray
11.6.1 Tilray Company Detail
11.6.2 Tilray Business Overview
11.6.3 Tilray New Psychoactive Substance Introduction
11.6.4 Tilray Revenue in New Psychoactive Substance Business (2018-2023)
11.6.5 Tilray Recent Development
11.7 Cyrelian
11.7.1 Cyrelian Company Detail
11.7.2 Cyrelian Business Overview
11.7.3 Cyrelian New Psychoactive Substance Introduction
11.7.4 Cyrelian Revenue in New Psychoactive Substance Business (2018-2023)
11.7.5 Cyrelian Recent Development
11.8 Anandia Laboratories
11.8.1 Anandia Laboratories Company Detail
11.8.2 Anandia Laboratories Business Overview
11.8.3 Anandia Laboratories New Psychoactive Substance Introduction
11.8.4 Anandia Laboratories Revenue in New Psychoactive Substance Business (2018-2023)
11.8.5 Anandia Laboratories Recent Development
11.9 InMed Pharmaceuticals
11.9.1 InMed Pharmaceuticals Company Detail
11.9.2 InMed Pharmaceuticals Business Overview
11.9.3 InMed Pharmaceuticals New Psychoactive Substance Introduction
11.9.4 InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023)
11.9.5 InMed Pharmaceuticals Recent Development
11.10 Renew Biopharma
11.10.1 Renew Biopharma Company Detail
11.10.2 Renew Biopharma Business Overview
11.10.3 Renew Biopharma New Psychoactive Substance Introduction
11.10.4 Renew Biopharma Revenue in New Psychoactive Substance Business (2018-2023)
11.10.5 Renew Biopharma Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Detail
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group New Psychoactive Substance Introduction
11.11.4 Cronos Group Revenue in New Psychoactive Substance Business (2018-2023)
11.11.5 Cronos Group Recent Development
11.12 ICC International Cannabis
11.12.1 ICC International Cannabis Company Detail
11.12.2 ICC International Cannabis Business Overview
11.12.3 ICC International Cannabis New Psychoactive Substance Introduction
11.12.4 ICC International Cannabis Revenue in New Psychoactive Substance Business (2018-2023)
11.12.5 ICC International Cannabis Recent Development
11.13 Biotii Technologies
11.13.1 Biotii Technologies Company Detail
11.13.2 Biotii Technologies Business Overview
11.13.3 Biotii Technologies New Psychoactive Substance Introduction
11.13.4 Biotii Technologies Revenue in New Psychoactive Substance Business (2018-2023)
11.13.5 Biotii Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global New Psychoactive Substance Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Stimulants
Table 3. Key Players of Cannabinoids
Table 4. Key Players of Hallucinogens
Table 5. Key Players of Depressants
Table 6. Global New Psychoactive Substance Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global New Psychoactive Substance Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global New Psychoactive Substance Market Share by Region (2018-2023)
Table 10. Global New Psychoactive Substance Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global New Psychoactive Substance Market Share by Region (2024-2033)
Table 12. New Psychoactive Substance Market Trends
Table 13. New Psychoactive Substance Market Drivers
Table 14. New Psychoactive Substance Market Challenges
Table 15. New Psychoactive Substance Market Restraints
Table 16. Global New Psychoactive Substance Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global New Psychoactive Substance Market Share by Players (2018-2023)
Table 18. Global Top New Psychoactive Substance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Table 19. Ranking of Global Top New Psychoactive Substance Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by New Psychoactive Substance Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players New Psychoactive Substance Product Solution and Service
Table 23. Date of Enter into New Psychoactive Substance Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global New Psychoactive Substance Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global New Psychoactive Substance Revenue Market Share by Type (2018-2023)
Table 27. Global New Psychoactive Substance Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global New Psychoactive Substance Revenue Market Share by Type (2024-2033)
Table 29. Global New Psychoactive Substance Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global New Psychoactive Substance Revenue Market Share by Application (2018-2023)
Table 31. Global New Psychoactive Substance Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global New Psychoactive Substance Revenue Market Share by Application (2024-2033)
Table 33. North America New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific New Psychoactive Substance Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific New Psychoactive Substance Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific New Psychoactive Substance Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa New Psychoactive Substance Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa New Psychoactive Substance Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa New Psychoactive Substance Market Size by Country (2024-2033) & (US$ Million)
Table 48. Zynerba Pharmaceuticals Company Detail
Table 49. Zynerba Pharmaceuticals Business Overview
Table 50. Zynerba Pharmaceuticals New Psychoactive Substance Product
Table 51. Zynerba Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 52. Zynerba Pharmaceuticals Recent Development
Table 53. GW Pharmaceuticals Company Detail
Table 54. GW Pharmaceuticals Business Overview
Table 55. GW Pharmaceuticals New Psychoactive Substance Product
Table 56. GW Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 57. GW Pharmaceuticals Recent Development
Table 58. Teewinot Life Sciences Company Detail
Table 59. Teewinot Life Sciences Business Overview
Table 60. Teewinot Life Sciences New Psychoactive Substance Product
Table 61. Teewinot Life Sciences Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 62. Teewinot Life Sciences Recent Development
Table 63. AusCann Company Detail
Table 64. AusCann Business Overview
Table 65. AusCann New Psychoactive Substance Product
Table 66. AusCann Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 67. AusCann Recent Development
Table 68. Cannabics Pharmaceuticals Company Detail
Table 69. Cannabics Pharmaceuticals Business Overview
Table 70. Cannabics Pharmaceuticals New Psychoactive Substance Product
Table 71. Cannabics Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 72. Cannabics Pharmaceuticals Recent Development
Table 73. Tilray Company Detail
Table 74. Tilray Business Overview
Table 75. Tilray New Psychoactive Substance Product
Table 76. Tilray Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 77. Tilray Recent Development
Table 78. Cyrelian Company Detail
Table 79. Cyrelian Business Overview
Table 80. Cyrelian New Psychoactive Substance Product
Table 81. Cyrelian Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 82. Cyrelian Recent Development
Table 83. Anandia Laboratories Company Detail
Table 84. Anandia Laboratories Business Overview
Table 85. Anandia Laboratories New Psychoactive Substance Product
Table 86. Anandia Laboratories Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 87. Anandia Laboratories Recent Development
Table 88. InMed Pharmaceuticals Company Detail
Table 89. InMed Pharmaceuticals Business Overview
Table 90. InMed Pharmaceuticals New Psychoactive Substance Product
Table 91. InMed Pharmaceuticals Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 92. InMed Pharmaceuticals Recent Development
Table 93. Renew Biopharma Company Detail
Table 94. Renew Biopharma Business Overview
Table 95. Renew Biopharma New Psychoactive Substance Product
Table 96. Renew Biopharma Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 97. Renew Biopharma Recent Development
Table 98. Cronos Group Company Detail
Table 99. Cronos Group Business Overview
Table 100. Cronos Group New Psychoactive Substance Product
Table 101. Cronos Group Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 102. Cronos Group Recent Development
Table 103. ICC International Cannabis Company Detail
Table 104. ICC International Cannabis Business Overview
Table 105. ICC International Cannabis New Psychoactive Substance Product
Table 106. ICC International Cannabis Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 107. ICC International Cannabis Recent Development
Table 108. Biotii Technologies Company Detail
Table 109. Biotii Technologies Business Overview
Table 110. Biotii Technologies New Psychoactive Substance Product
Table 111. Biotii Technologies Revenue in New Psychoactive Substance Business (2018-2023) & (US$ Million)
Table 112. Biotii Technologies Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global New Psychoactive Substance Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global New Psychoactive Substance Market Share by Type: 2022 VS 2033
Figure 3. Stimulants Features
Figure 4. Cannabinoids Features
Figure 5. Hallucinogens Features
Figure 6. Depressants Features
Figure 7. Global New Psychoactive Substance Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global New Psychoactive Substance Market Share by Application: 2022 VS 2033
Figure 9. Cancer Case Studies
Figure 10. Neuropathic Disorders Case Studies
Figure 11. Spasticity Case Studies
Figure 12. Others Case Studies
Figure 13. New Psychoactive Substance Report Years Considered
Figure 14. Global New Psychoactive Substance Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global New Psychoactive Substance Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global New Psychoactive Substance Market Share by Region: 2022 VS 2033
Figure 17. Global New Psychoactive Substance Market Share by Players in 2022
Figure 18. Global Top New Psychoactive Substance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Psychoactive Substance as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by New Psychoactive Substance Revenue in 2022
Figure 20. North America New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 22. United States New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe New Psychoactive Substance Market Share by Country (2018-2033)
Figure 26. Germany New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific New Psychoactive Substance Market Share by Region (2018-2033)
Figure 34. China New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America New Psychoactive Substance Market Share by Country (2018-2033)
Figure 42. Mexico New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa New Psychoactive Substance Market Share by Country (2018-2033)
Figure 46. Turkey New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia New Psychoactive Substance Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Zynerba Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 50. Teewinot Life Sciences Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 51. AusCann Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 52. Cannabics Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 53. Tilray Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 54. Cyrelian Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 55. Anandia Laboratories Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 56. InMed Pharmaceuticals Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 57. Renew Biopharma Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 58. Cronos Group Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 59. ICC International Cannabis Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 60. Biotii Technologies Revenue Growth Rate in New Psychoactive Substance Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed